Trial intelligence / Profile preview

Boswellia gel for symptom improvement in psoriasis

IRCT20240622062209N1Phase 3Completed

Sponsor
Vice Chancellor for Research, Birjand University of Medical Sciences
Start
Aug 2024
Countries
1
01

Overview

Phase 3 trial of boswellia serrata in psoriasis, sponsored by Vice Chancellor for Research, Birjand University of Medical Sciences. Started Aug 2024; status: completed.

02

Drugs

boswellia serrata
03

Conditions

psoriasis

Beyond the preview

Go deeper on IRCT20240622062209N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20240622062209N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call